This inventor holds 234 USPTO granted patents and 109 published patent applications, plus 1 CIPO patent and 158 EPO patents, primarily in Pharmaceutical Compounds (CPC class A61P35-00). Top assignees: Medshine Discovery Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Guangdong Raynovent Biotech Co., Ltd.. Active years: 2017-2026.
Inventors with similar research interests:
Company Filing History:
59 out of 72 
21 out of 121 
9 out of 13 Years Active: 2017-2026
Areas of Expertise:
Title: Shuhui Chen: Innovative Solutions and Patents in Shanghai
Introduction:
Shuhui Chen, a prolific inventor based in Shanghai, China, has made significant contributions to the field of pharmaceuticals and related industries. With an impressive number of 136 patents to his name, Chen has consistently demonstrated his expertise and innovative thinking. This article sheds light on his latest patents, his career highlights, and his valuable collaborations with notable colleagues.
Latest Patents:
Chen's most recent patents highlight his contributions to the development of novel compounds with potential therapeutic applications. One of his noteworthy patents is titled "Benzo 2-azaspiro[4.4]nonane compound and use thereof." This patent discloses a series of benzo 2-azaspiro[4.4]nonane compounds, with a specific emphasis on a compound represented by formula (P) and its pharmaceutically acceptable salt. This breakthrough has the potential to pave the way for new treatments in the medical industry.
Another remarkable patent is titled "Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound." This patent introduces a crystal form (formula I) of a 2-methyl-2-propanol and amino-substituted aryl compound, along with its preparation method. The crystal form's application in the manufacturing of medicines for treating related diseases showcases Chen's ability to harness materials for therapeutic purposes effectively.
Career Highlights:
Chen's impressive 136 patents reflect his extensive experience and expertise. Throughout his career, he has worked with leading companies in the pharmaceutical sector, including Medshine Discovery Inc. and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. These collaborations have provided Chen with invaluable opportunities to apply and further develop his inventive ideas within a professional setting.
Collaborations:
One of Chen's notable collaborators is Jian Li, a distinguished individual who has contributed significantly to the pharmaceutical industry. The partnership between Chen and Li has likely fueled groundbreaking discoveries and advancements. Additionally, Charles Z Ding, another colleague, has contributed to Chen's journey as a valuable collaborator. Together, they may have pushed the boundaries of innovation and invention in pharmaceuticals.
Conclusion:
Shuhui Chen's remarkable record of 136 patents underscores his immense capability as an inventive mind in the field of pharmaceuticals. His latest patents, such as the benzo 2-azaspiro[4.4]nonane compound and the crystal form of 2-methyl-2-propanol and amino-substituted aryl compound, demonstrate his commitment to finding novel solutions with potential therapeutic applications.
Chen's collaborations with prominent individuals like Jian Li and Charles Z Ding have likely played a pivotal role in harnessing collective expertise and pushing forward innovative ideas. As Chen continues his journey, it will be fascinating to see what groundbreaking contributions he will make next, further advancing the realm of pharmaceuticals.